Efficacy and safety of dupilumab in the treatment of moderate-to-severe atopic dermatitis: a real-life study.

Saved in:

Bibliographic Details
Title:	Efficacy and safety of dupilumab in the treatment of moderate-to-severe atopic dermatitis: a real-life study.
Authors:	Lopes MM; Division of Clinical Immunology and Allergy, School of Medicine, University of São Paulo, São Paulo, Brazil.; Croce Clinic, São Paulo, São Paulo, Brazil., Castro APM; Division of Clinical Immunology and Allergy, School of Medicine, University of São Paulo, São Paulo, Brazil.; Croce Clinic, São Paulo, São Paulo, Brazil., Ferrisse TM; School of Dentistry, São Paulo State University (UNESP), Araraquara, São Paulo, Brazil., Kalil J; Division of Clinical Immunology and Allergy, School of Medicine, University of São Paulo, São Paulo, Brazil., Yang AC; Division of Clinical Immunology and Allergy, School of Medicine, University of São Paulo, São Paulo, Brazil., Castro FM; Division of Clinical Immunology and Allergy, School of Medicine, University of São Paulo, São Paulo, Brazil.; Croce Clinic, São Paulo, São Paulo, Brazil.
Source:	Drugs in context [Drugs Context] 2025 Jun 19; Vol. 14. Date of Electronic Publication: 2025 Jun 19 (Print Publication: 2025).
Publication Type:	Journal Article
Journal Info:	Publisher: Bioexcel Publishing Ltd Country of Publication: England NLM ID: 101262187 Publication Model: eCollection Cited Medium: Print ISSN: 1745-1981 (Print) Linking ISSN: 17404398 NLM ISO Abbreviation: Drugs Context Subsets: PubMed not MEDLINE
Database:	MEDLINE Ultimate

Description
ISSN:	1745-1981
DOI:	10.7573/dic.2025-3-5